{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:18:43Z","timestamp":1773674323589,"version":"3.50.1"},"reference-count":134,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jconrel.2012.05.051","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T00:55:15Z","timestamp":1339548915000},"page":"45-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":265,"title":["Nanotechnology applied to overcome tumor drug resistance"],"prefix":"10.1016","volume":"162","author":[{"given":"Zibin","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2012.05.051_bb0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1040-8428(00)00086-X","article-title":"Multicellular resistance: a paradigm for clinical resistance?","volume":"36","author":"Desoize","year":"2000","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2012.05.051_bb0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000086183","article-title":"Mechanisms of drug resistance in cancer chemotherapy","volume":"14","author":"Luqmani","year":"2005","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/02841869209088904","article-title":"Mechanisms of multidrug resistance in cancer treatment","volume":"31","author":"Harris","year":"1992","journal-title":"Acta Oncol."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60761-416-6_1","article-title":"Multidrug resistance in cancer","volume":"596","author":"Baguley","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0035","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1158\/0008-5472.CAN-04-0001","article-title":"Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system","volume":"64","author":"Pakunlu","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0040","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2217\/17435889.3.6.761","article-title":"Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer","volume":"3","author":"Saad","year":"2008","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.nano.2010.12.009","article-title":"Pharmacokinetics and biodistribution of lonidamine\/paclitaxel loaded. EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer","volume":"7","author":"Milane","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2009.01.021","article-title":"Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance","volume":"136","author":"Patil","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0055","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.biomaterials.2009.09.080","article-title":"The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin","volume":"31","author":"Xiong","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0060","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1016\/j.biomaterials.2010.02.053","article-title":"Imaging and inhibition of multi-drug resistance in cancer cells via specific association with negatively charged CdTe quantum dots","volume":"31","author":"Zhou","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0065","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nano.2011.06.005","article-title":"Gold-doxorubicin nanoconjugates for overcoming multidrug resistance","volume":"8","author":"Gu","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0070","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejps.2011.08.028","article-title":"Overcoming cellular multidrug resistance using classical nanomedicine formulations","volume":"45","author":"Kunjachan","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejps.2010.11.006","article-title":"Polymer conjugates of the highly potent cytostatic drug 2-pyrrolinodoxorubicin","volume":"42","author":"Studenovsky","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0080","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.biomaterials.2007.12.017","article-title":"Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin","volume":"29","author":"Kono","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0085","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.copbio.2011.04.008","article-title":"Minicells: versatile vectors for targeted drug or si\/shRNA cancer therapy","volume":"22","author":"MacDiarmid","year":"2011","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0090","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0095","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.95.8.4607","article-title":"Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment","volume":"95","author":"Hobbs","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0100","first-page":"1172","article-title":"The potential of drug-carrying immunoliposomes as anticancer agents","volume":"8","author":"Siwak","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0105","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0002-9440(10)65006-7","article-title":"Openings between defective endothelial cells explain tumor vessel leakiness","volume":"156","author":"Hashizume","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0110","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.0408422102","article-title":"Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium","volume":"102","author":"Zhao","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00726-009-0261-8","article-title":"Tumor-targeting amino acid auxotrophic Salmonella typhimurium","volume":"37","author":"Hoffman","year":"2009","journal-title":"Amino Acids"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nnano.2009.314","article-title":"Design considerations for tumour-targeted nanoparticles","volume":"5","author":"Choi","year":"2010","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0125","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1016\/j.biomaterials.2004.10.012","article-title":"Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications","volume":"26","author":"Gupta","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jconrel.2004.12.018","article-title":"Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor","volume":"103","author":"Lee","year":"2005","journal-title":"J Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0135","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nano.2011.06.011","article-title":"A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells","volume":"8","author":"Lin","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","article-title":"Tumor delivery of macromolecular drugs based on the EPR effect","volume":"63","author":"Torchilin","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0145","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/bjc.1993.179","article-title":"Augmentation of tumour delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure","volume":"67","author":"Li","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0150","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2745\/dds.22.510","article-title":"SMANCS dynamic therapy for various advanced solid tumors and promising clinical effects: enhanced drug delivery by hydrodynamic modulation with vascular mediators, particularly angiotensin II, during arterial infusion","volume":"22\u20135","author":"Nagamitsu","year":"2007","journal-title":"Drug Deliv. Syst."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0155","first-page":"4129","article-title":"Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor","volume":"59","author":"Monsky","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jps.2600840420","article-title":"Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system","volume":"84","author":"Bazile","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0165","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1073\/pnas.85.18.6949","article-title":"Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors","volume":"85","author":"Gabizon","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0170","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1517\/17460441.3.11.1293","article-title":"Designing PEGylated therapeutic molecules: advantages in ADMET properties","volume":"3","author":"Hamidi","year":"2008","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0180","first-page":"5","article-title":"Pegnology: a review of PEG-ylated systems","volume":"57","author":"Bhadra","year":"2002","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0185","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1602\/neurorx.2.1.108","article-title":"Drug transport to brain with targeted nanoparticles","volume":"2","author":"Olivier","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0190","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.addr.2008.08.002","article-title":"Hydrogel nanoparticles in drug delivery","volume":"60","author":"Hamidi","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0195","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1021\/mp060039w","article-title":"Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells","volume":"3","author":"Li","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijpharm.2010.05.028","article-title":"Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs","volume":"395","author":"Galmarini","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0205","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejpb.2010.06.011","article-title":"Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin","volume":"76","author":"Jiang","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1021\/bc800239b","article-title":"Cytoplasmic delivery of liposomal contents mediated by an acid-labile cholesterol-vinyl ether-PEG conjugate","volume":"20","author":"Boomer","year":"2009","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0215","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1016\/j.biomaterials.2010.02.049","article-title":"Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes","volume":"31","author":"Xu","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0220","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jconrel.2008.04.024","article-title":"Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance","volume":"129","author":"Lee","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0225","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.nantod.2011.08.002","article-title":"Emerging nanomaterials for targeting subcellular organelles","volume":"6","author":"Huang","year":"2011","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0230","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/jpet.107.127704","article-title":"Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells","volume":"324","author":"Shen","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0240","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2008.11.010","article-title":"Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect","volume":"71","author":"Maeda","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0245","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1016\/j.biomaterials.2005.02.038","article-title":"Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes","volume":"26","author":"Dinauer","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0250","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0255","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.addr.2008.08.005","article-title":"Active targeting schemes for nanoparticle systems in cancer therapeutics","volume":"60","author":"Byrne","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0260","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1023\/B:PHAM.0000022411.47059.76","article-title":"The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers","volume":"21","author":"Qaddoumi","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(03)00295-3","article-title":"Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d, l-lactide-co-glycolide) nanoparticles","volume":"262","author":"Panyam","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0270","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1073\/pnas.150228297","article-title":"High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment","volume":"97","author":"Wu","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0275","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.biomaterials.2006.10.012","article-title":"Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers","volume":"28","author":"Zhao","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0280","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2008.01.014","article-title":"Overcoming the formulation obstacles towards targeted chemotherapy: in vitro and in vivo evaluation of cytotoxic drug loaded immunonanoparticles","volume":"127","author":"Debotton","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0285","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tibtech.2008.06.007","article-title":"Does a targeting ligand influence nanoparticle tumor localization or uptake?","volume":"26","author":"Pirollo","year":"2008","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0290","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrc1958","article-title":"Polymer conjugates as anticancer nanomedicines","volume":"6","author":"Duncan","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0295","first-page":"3352","article-title":"Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft","volume":"54","author":"Yuan","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0300","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.biomaterials.2009.09.103","article-title":"The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model","volume":"31","author":"Xu","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0305","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nbt.1547","article-title":"Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug","volume":"27","author":"MacDiarmid","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0310","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.biomaterials.2009.09.048","article-title":"The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance","volume":"31","author":"Patil","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0315","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1016\/j.biomaterials.2010.02.007","article-title":"Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles","volume":"31","author":"Wang","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0320","first-page":"350","article-title":"Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil","volume":"10","author":"Wu","year":"2007","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0325","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1021\/nn9011225","article-title":"P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells","volume":"4","author":"Li","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0330","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0165-6147(88)90078-8","article-title":"Regulation of endocytic processes by pH","volume":"9","author":"Yamashiro","year":"1988","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0335","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00280-008-0790-y","article-title":"Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells","volume":"63","author":"Yadav","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0340","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2011.01.024","article-title":"Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro","volume":"152","author":"Kievit","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0345","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2008.04.016","article-title":"Multi-functional nanocarriers for targeted delivery of drugs and genes","volume":"130","author":"Jabr-Milane","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0350","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/02656739509022457","article-title":"Extracellular pH distribution in human tumours","volume":"11","author":"Engin","year":"1995","journal-title":"Int. J. Hyperthermia"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0355","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.biomaterials.2008.12.036","article-title":"The role of hydrophobic amino acid grafts in the enhancement of membrane-disruptive activity of pH-responsive pseudo-peptides","volume":"30","author":"Chen","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0360","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0163-7258(99)00073-X","article-title":"Resistance mechanisms associated with altered intracellular distribution of anticancer agents","volume":"85","author":"Larsen","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0365","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nano.2008.09.003","article-title":"Degradable poly(beta-amino ester) nanoparticles for cancer cytoplasmic drug delivery","volume":"5","author":"Shen","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0370","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nano.2010.06.010","article-title":"Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody","volume":"7","author":"Wang","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0375","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijpharm.2010.10.038","article-title":"Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles","volume":"404","author":"Fan","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0380","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1021\/nl070345g","article-title":"Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells","volume":"7","author":"Chen","year":"2007","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0385","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1016\/j.biomaterials.2011.08.014","article-title":"Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy","volume":"32","author":"Hua","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0390","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2011.06.005","article-title":"Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo","volume":"155","author":"Lu","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0395","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/nl101157z","article-title":"Targeted cytosolic delivery of cell-impermeable compounds by nanoparticle-mediated, light-triggered endosome disruption","volume":"10","author":"Febvay","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0400","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jphotobiol.2008.07.009","article-title":"Synergistic cytotoxic effect of different sized ZnO nanoparticles and daunorubicin against leukemia cancer cells under UV irradiation","volume":"93","author":"Guo","year":"2008","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0405","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.biomaterials.2011.11.015","article-title":"Plasmonic nanobubble-enhanced endosomal escape processes for selective and guided intracellular delivery of chemotherapy to drug-resistant cancer cells","volume":"33","author":"Lukianova-Hleb","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0410","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jconrel.2011.03.017","article-title":"Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7\/ADR cells","volume":"152","author":"Shieh","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0415","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2003.09.048","article-title":"Combined cancer therapy by micellar-encapsulated drug and ultrasound","volume":"277","author":"Rapoport","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0420","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/bbrc.2001.5938","article-title":"Overcoming MDR by ultrasound-induced hyperthermia and P-glycoprotein modulation","volume":"289","author":"Liu","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0425","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(02)00262-6","article-title":"Drug delivery in pluronic micelles: effect of high-frequency ultrasound on drug release from micelles and intracellular uptake","volume":"84","author":"Marin","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0430","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.nano.2010.05.005","article-title":"Advances in polymeric micelles for drug delivery and tumor targeting","volume":"6","author":"Kedar","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0435","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00137696-200604020-00005","article-title":"Ultrasound-enhanced chemotherapy of drug-resistant breast cancer tumors by micellar-encapsulated paclitaxel","volume":"4","author":"Howard","year":"2006","journal-title":"Am. J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0440","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2011.03.032","article-title":"Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology","volume":"155","author":"Milane","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0445","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0014-827X(02)01229-6","article-title":"The medicinal chemistry of multidrug resistance (MDR) reversing drugs","volume":"57","author":"Teodori","year":"2002","journal-title":"Farmaco"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0450","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00432-007-0323-9","article-title":"Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice","volume":"134","author":"Hubensack","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0455","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/156800908783497168","article-title":"Targeting P-glycoprotein for effective oral anti-cancer chemotherapeutics","volume":"8","author":"Bebawy","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0460","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.euroneuro.2007.06.003","article-title":"A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs","volume":"18","author":"Linnet","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0465","first-page":"2598","article-title":"Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans","volume":"6","author":"van Zuylen","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0470","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejps.2009.02.018","article-title":"Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles","volume":"37","author":"Song","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0475","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1158\/1078-0432.CCR-07-4973","article-title":"Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles","volume":"14","author":"Devalapally","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0480","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.biomaterials.2011.06.028","article-title":"Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic(R) for tumor-targeted delivery of docetaxel","volume":"32","author":"Cho","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0485","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1016\/j.biomaterials.2011.06.066","article-title":"A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance","volume":"32","author":"He","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0490","article-title":"Lapatinib\/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer","author":"Vergara","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0495","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jconrel.2009.08.013","article-title":"Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel","volume":"140","author":"Liu","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0500","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jconrel.2006.06.010","article-title":"In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug","volume":"114","author":"Pakunlu","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0505","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1021\/nn100690m","article-title":"Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line","volume":"4","author":"Meng","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0510","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.biomaterials.2011.10.085","article-title":"Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma","volume":"33","author":"Yu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0515","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1016\/j.biomaterials.2011.04.029","article-title":"The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells","volume":"32","author":"Wang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0520","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","article-title":"Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers","volume":"130","author":"Batrakova","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0525","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2010.01.004","article-title":"Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers","volume":"143","author":"Batrakova","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0530","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.actbio.2009.11.035","article-title":"A novel paclitaxel-loaded poly(epsilon-caprolactone)\/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment","volume":"6","author":"Zhang","year":"2010","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0535","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijpharm.2011.10.003","article-title":"Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance","volume":"422","author":"Ji","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0540","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.biomaterials.2010.12.039","article-title":"Multifunctional pluronic P123\/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors","volume":"32","author":"Zhang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0545","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.biomaterials.2010.01.015","article-title":"An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0550","first-page":"1195","article-title":"Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin","volume":"32","author":"Riehm","year":"1972","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0555","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/bjc.1993.338","article-title":"Interaction of multidrug-resistant Chinese hamster ovary cells with amphiphiles","volume":"68","author":"Loe","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0560","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-3057(73)90063-3","article-title":"Poly[N-(2-hydroxypropyl)methacrylamide]. I. Radical polymerization and copolymerization","volume":"9","author":"Kopecek","year":"1973","journal-title":"Eur. Polym."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0565","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/jbm.820100612","article-title":"New types of synthetic infusion solutions. III. Elimination and retention of poly-[N-(2-hydroxypropyl)methacrylamide] in a test organism","volume":"10","author":"Sprincl","year":"1976","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0570","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1016\/j.biomaterials.2011.02.059","article-title":"Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances","volume":"32","author":"Segal","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0575","first-page":"e63","article-title":"HPMAcopolymerconjugates for dualtherapy","volume":"132","author":"Etrycha","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0580","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijpharm.2007.09.018","article-title":"Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugs","volume":"351","author":"Hongrapipat","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0585","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jconrel.2010.12.015","article-title":"Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy","volume":"151","author":"Greish","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0590","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejpb.2011.10.020","article-title":"Synthesis and in vitro anti-tumor activity of novel HPMA copolymer\u2013drug conjugates with potential cell surface targeting property for carcinoma cells","volume":"80","author":"Xiang","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0595","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.biomaterials.2011.12.007","article-title":"Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates","volume":"33","author":"Yang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0600","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2008.07.014","article-title":"Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A''-DTPA) conjugates show increased kidney accumulation","volume":"132","author":"Borgman","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0605","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2004.09.023","article-title":"Targeting tumor angiogenic vasculature using polymer-RGD conjugates","volume":"102","author":"Mitra","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0610","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-3659(98)00124-2","article-title":"Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine","volume":"57","author":"Julyan","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0615","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jconrel.2011.07.009","article-title":"HPMA-oligolysine copolymers for gene delivery: optimization of peptide length and polymer molecular weight","volume":"155","author":"Johnson","year":"2011","journal-title":"J. Control. Release"},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2012.05.051_bb0620","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/j.jconrel.2011.08.068","article-title":"Preparation and characterization of guanidinated N-3-aminopropyl methacrylamide-N-2-hydroxypropyl methacrylamide copolymers as gene delivery carriers","volume":"152","author":"Qin","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0625","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2011.08.015","article-title":"Reducible HPMA-co-oligolysine copolymers for nucleic acid delivery","volume":"427","author":"Shi","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0630","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2007.06.007","article-title":"Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy","volume":"122","author":"Etrych","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0635","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2009.05.007","article-title":"Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt","volume":"61","author":"Duncan","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.051_bb0640","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2011.03.030","article-title":"Conformational consequences of cooperative binding of a coiled-coil peptide motif to poly(N-(2-hydroxypropyl) methacrylamide) HPMA copolymers","volume":"153","author":"Griffiths","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0645","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/10611860701499946","article-title":"Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: insights of the mechanism of action","volume":"15","author":"Zalipsky","year":"2007","journal-title":"J. Drug Target"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0650","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0168-3659(98)00009-1","article-title":"HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line","volume":"54","author":"Minko","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0655","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-3659(98)00186-2","article-title":"Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line","volume":"59","author":"Minko","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0660","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0142-9612(00)00161-7","article-title":"Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance","volume":"21","author":"Tijerina","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0665","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0168-3659(01)00220-6","article-title":"Preliminary evaluation of caspasesdependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells","volume":"71","author":"Minko","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.051_bb0670","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.addr.2009.12.002","article-title":"HPMA copolymers for modulating cellular signaling and overcoming multidrug resistance","volume":"62","author":"Minko","year":"2010","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912004932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912004932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:26:11Z","timestamp":1759159571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365912004932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0168365912004932"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2012.05.051","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology applied to overcome tumor drug resistance","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2012.05.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}